Press Releases

Investor Resources
Contact Us
Investor ResourcesPress Releases

Press Releases

Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™


December 22, 2020

Cardiol Therapeutics Appoints Worldwide Clinical Trials as CRO for the Company’s Phase II/III Outcomes Trial in High-risk Patients Hospitalized with COVID-19


December 15, 2020

Cardiol Therapeutics’ Cortalex™ CBD Now Available Exclusively Online at Medical Cannabis by Shoppers Inc.


October 20, 2020

Cardiol Therapeutics Receives FDA Approval for Investigational New Drug (IND) Application for Phase II/III COVID-19 Trial


September 25, 2020

Cardiol Therapeutics to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference


September 15, 2020

Cardiol Therapeutics Initiates Health Canada Approved Phase 1 Clinical Study of CardiolRx™


August 26, 2020

Cardiol Therapeutics Appoints CNBC Market Analyst Steven Grasso as Business Advisor


June 29, 2020

David Elsley Files Early Warning Report for Cardiol Therapeutics


June 25, 2020

Cardiol Therapeutics Closes $17.25 Million Bought Deal Offering, Including Full Exercise of the Over-Allotment Option


June 4, 2020

2024 Cardiol Therapeutics. All right reserved.